MEDICAPQ logo

MEDI CAPS LTD.

MEDICAPQ·BSE·
₹25.70▼ -0.29 (-1.12%)
Market Cap31.18 Cr
PE Ratio-24.50
Volume50
Day High - Low25.70 - 25.70
52W High-Low36.80 - 20.33

Medi Caps Ltd. (MEDICAPQ): company summary

The company's business has deteriorated significantly, with annual revenue falling 51.1% and annual net profit turning into a loss that widened from ₹1 crore to ₹3 crore.

Medi Caps Ltd. (MEDICAPQ) is a micro-cap Healthcare company valued at ₹31 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Medi Caps Ltd. last traded at ₹25.7, modestly down 1.12% on the day.
Recent developments
2026-09-30: Promoter holding remained at 51.44%, indicating no change in ownership structure. 2026-06-30: The company reported a net loss of ₹2 crore for the latest quarter, reflecting a narrowing loss compared to the prior quarter's ₹3 crore.
Financial performance
The company's business has deteriorated significantly, with annual revenue falling 51.1% and annual net profit turning into a loss that widened from ₹1 crore to ₹3 crore. The latest quarter shows a slight improvement, with net profit loss narrowing from ₹3 crore to ₹2 crore, though revenue remained flat compared to the same quarter a year earlier.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.39 times book value.
Things to watch
The company reported a net loss of ₹3 crore in its latest financial year, with net profit margin worsening to -24.4% from -2.2% a year earlier. The latest quarter's net loss of ₹2 crore, while narrower than the prior quarter, highlights ongoing profitability challenges.
Where it stands
The company continues to operate at a loss, with net profit margin deteriorating sharply and annual net profit turning into a loss that widened. The latest quarter's net loss of ₹2 crore marks a slight improvement, but the overall financial position remains weak.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
2.7/10
Poor
Fair Value
Sign in to see
ROE
-2.72%
Weak
P/E
-24.50x
Loss-making
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W₹20.33
₹36.80
DocStoX take

Supported by growth (7.5) and valuation (6.0), but held back by quality (0.0). Growth looks strong at 7.5, but that is offset by quality at 0.0 and momentum at 2.5. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
2.7
/10
Poor
Quality
Weak
ROE -2.7%
Valuation
Fair
P/B 0.4× on assets (no earnings to value)
Growth
Strong
Revenue +399.3% 3Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Weak
33% of 52-week range

At a glance

Market Cap
₹31 Cr
52W High / Low
₹37 / ₹20
Dividend Yield
0.00%
Promoter Holding
51.44%
EPS (TTM)
₹-2.44
Book Value
₹89.50

Key highlights

  • Revenue compounding 399% a year
  • Low leverage — D/E 0.00
  • Loss-making — no meaningful P/E
  • Loss-making in some of the last 5 years
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

MEDI CAPS LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.